The link below connects to a new paper which reviews a novel hypoxia marker – HypoxiTRAK™ – a homogeneous live-cell permeant reagent which provides a …
Read more
Hypoxia signaling – Challenges and opportunities for cancer therapy
This review focuses on new pharmacological agents that exploit tumor hypoxia or interfere with hypoxia signaling and discusses strategies to maximize their therapeutic impact. Click …
Read more
Hypoxia Researchers win Nobel prize!
The Nobel Prize in Physiology or Medicine 2019 has been awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza …
Read more
OCT1002 shows promising results in prostate cancer research
Researchers at Ulster University have just published the latest results of a three-year study looking at OCT1002 in combination with hormone therapy in prostate cancer. The …
Read more